PM-43I

N/A

Report date: 2025/01/26 16:46:10
NME

Base Information

Drug NamePM-43I
Drug Alias NameSTAT6 inhibitor (Atrapos Therapeutics)PM-43I
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionSTAT5 transcription factor inhibitorsSignal transducer and activator of transcription 6 inhibitors
TargetsSignal transducer and activator of transcription 6STAT5 transcription factor
Therapy Area/IndicationsDermatitis, AtopicIdiopathic Pulmonary FibrosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesAtrapos Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicIdiopathic Pulmonary FibrosisAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A